AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18562265 — intervention group
Group type: COMPARATOR
Intervention: No wound drains
Number of subjects: 107
Study 17460714 — intervention group
Group type: EXPERIMENTAL
Intervention: Once daily ramipril 10 mg
Number of subjects: 29
Study 17460714 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice daily ramipril 5 mg
Number of subjects: 29
Study 15827396 — intervention group
Group type: EXPERIMENTAL
Intervention: CCK10 plus GTN
Number of subjects: 31
Study 15827396 — intervention group
Group type: COMPARATOR
Intervention: CCK10 alone
Number of subjects: 31
Study 15827396 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus CCK10
Number of subjects: 31
Study 12475452 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisone for 45 days
Number of subjects: 83
Study 12475452 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 45 days
Number of subjects: 83
Study 9972754 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (25-200 microg)
Number of subjects: 40
Study 9972754 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled analgesia with i.v. morphine (historical group)
Number of subjects: 40
Study 7476333 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin (FLUV) 40 mg/d
Number of subjects: 100
Study 7476333 — intervention group
Group type: COMPARATOR
Intervention: Cholestyramine (CME) 16 g/d
Number of subjects: 100
Study 1827213 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide delivered by metered-dose aerosol plus spacer and mask (MDA group)
Number of subjects: 32
Study 1827213 — intervention group
Group type: COMPARATOR
Intervention: Ipratropium bromide delivered by conventional nebulisation
Number of subjects: 32
Study 7053953 — intervention group
Group type: COMPARATOR
Intervention: Manufacturer's instruction sheet
Number of subjects: 42
Study 7053953 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling from a pharmacist
Number of subjects: 42
Study 7053953 — intervention group
Group type: EXPERIMENTAL
Intervention: Both manufacturer's instruction sheet and counseling from a pharmacist
Number of subjects: 42
Study 30395051 — intervention group
Group type: EXPERIMENTAL
Intervention: Impact loading + resistance training (ImpRes)
Number of subjects: 154
Study 30395051 — intervention group
Group type: COMPARATOR
Intervention: Delayed aerobic exercise (DelAer)
Number of subjects: 154
Study 28338164 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic repair (LR)
Number of subjects: 119
Study 28338164 — intervention group
Group type: COMPARATOR
Intervention: Open repair (OR)
Number of subjects: 119
Study 27969034 — intervention group
Group type: EXPERIMENTAL
Intervention: Support Program
Number of subjects: 70
Study 27969034 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 70
Study 23183194 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT-D
Number of subjects: 1820
Study 21468625 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic gastric bypass (LGBP)
Number of subjects: 68
Study 21468625 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 68
Study 18479627 — intervention group
Group type: EXPERIMENTAL
Intervention: No drain
Number of subjects: 55
Study 18479627 — intervention group
Group type: COMPARATOR
Intervention: Drain
Number of subjects: 55
Study 16432111 — intervention group
Group type: EXPERIMENTAL
Intervention: PRECiSe low prime volume system
Number of subjects: 80
Study 16432111 — intervention group
Group type: COMPARATOR
Intervention: Standard heart-lung machine
Number of subjects: 80
Study 12676276 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium taste preference in hemodialysis patients
Number of subjects: 20
Study 12676276 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium taste preference in cheese
Number of subjects: 20
Study 12676276 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium appetite related to perturbed calcium metabolism
Number of subjects: 20
Study 12676276 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium added to foods for hemodialysis patients
Number of subjects: 20
Study 10743489 — intervention group
Group type: EXPERIMENTAL
Intervention: High flavour level yoghurt
Number of subjects: 380
Study 10743489 — intervention group
Group type: COMPARATOR
Intervention: Low flavour level yoghurt
Number of subjects: 380
Study 10743489 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavour-amplified yoghurt
Number of subjects: 380
Study 10743489 — intervention group
Group type: EXPERIMENTAL
Intervention: Age, sex, BMI, and odour perception
Number of subjects: 380
Study 10743489 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 380
Study 10743489 — intervention group
Group type: EXPERIMENTAL
Intervention: Odour perception
Number of subjects: 380
Study 9374950 — intervention group
Group type: EXPERIMENTAL
Intervention: Same admission cardiac catheterization
Number of subjects: 100
Study 9374950 — intervention group
Group type: COMPARATOR
Intervention: Year of admission
Number of subjects: 100
Study 9374950 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrence of chest pain and evidence of myocardial necrosis
Number of subjects: 100
Study 1357242 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithotripsy
Number of subjects: 163
Study 1357242 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecystectomy
Number of subjects: 163
Study 3920891 — intervention group
Group type: EXPERIMENTAL
Intervention: verapamil
Number of subjects: 17
Study 3920891 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 17
Study 30073685 — intervention group
Group type: EXPERIMENTAL
Intervention: Blinded sample size reestimation procedures
Number of subjects: 0
Study 30073685 — intervention group
Group type: EXPERIMENTAL
Intervention: Unblinded sample size reestimation procedures
Number of subjects: 0
Study 30073685 — intervention group
Group type: COMPARATOR
Intervention: Conventional SW-CRT design
Number of subjects: 0
Study 28994889 — intervention group
Group type: EXPERIMENTAL
Intervention: Beat-to-beat heart rate slope during six-minute walk test (6MWTS)
Number of subjects: 70
Study 28994889 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery slope
Number of subjects: 70
Study 25556427 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (500mg Bid)
Number of subjects: 43
Study 25556427 — intervention group
Group type: COMPARATOR
Intervention: Megestrol (40mg daily)
Number of subjects: 43
Study 22223747 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonomed UBM (SUBM)
Number of subjects: 27
Study 22223747 — intervention group
Group type: COMPARATOR
Intervention: Humphrey UBM (HUBM)
Number of subjects: 27
Study 20131372 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q(10)
Number of subjects: 0
Study 20131372 — intervention group
Group type: EXPERIMENTAL
Intervention: GPI-1485
Number of subjects: 0
Study 20131372 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18597597 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP and laser (SRPL)
Number of subjects: 21
Study 18597597 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser only (L)
Number of subjects: 21
Study 18597597 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP only (SRP)
Number of subjects: 21
Study 18597597 — intervention group
Group type: COMPARATOR
Intervention: No treatment (C)
Number of subjects: 21
Study 17697395 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 18
Study 17697395 — intervention group
Group type: COMPARATOR
Intervention: Control (healthy age-matched subjects)
Number of subjects: 18
Study 14990521 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT)
Number of subjects: 0
Study 14990521 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive counselling
Number of subjects: 0
Study 14990521 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study 11403713 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 Hz magnetic field exposure (28 microT, circularly polarized) for 50 minutes
Number of subjects: 30
Study 11403713 — intervention group
Group type: COMPARATOR
Intervention: Sham exposure (control) for 50 minutes
Number of subjects: 30
Study 9240942 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin thromboprophylaxis
Number of subjects: 3809
Study 8497679 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline (500 micrograms)
Number of subjects: 21
Study 8497679 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline plus ipratropium bromide (20 micrograms)
Number of subjects: 21
Study 3545941 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacampicillin 400 mg twice daily
Number of subjects: 953
Study 3545941 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacampicillin 800 mg twice daily
Number of subjects: 953
Study 3545941 — intervention group
Group type: COMPARATOR
Intervention: Three times daily dosages of bacampicillin, ampicillin, amoxycillin
Number of subjects: 953
Study 3545941 — intervention group
Group type: COMPARATOR
Intervention: Co-trimoxazole twice daily
Number of subjects: 953
Study 31821154 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital self-monitoring intervention (EMPOWER) using a mobile app for early warning signs monitoring.
Number of subjects: 0
Study 29475554 — intervention group
Group type: EXPERIMENTAL
Intervention: DIAGNOdent (KaVo)
Number of subjects: 1500
Study 29475554 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectra (Air Techniques)
Number of subjects: 1500
Study 29475554 — intervention group
Group type: COMPARATOR
Intervention: No device
Number of subjects: 1500
Study 27829457 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention group receiving dietary advice
Number of subjects: 70
Study 27829457 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving only advice on the care and maintenance of dentures
Number of subjects: 70
Study 24704505 — intervention group
Group type: EXPERIMENTAL
Intervention: Live attenuated tetravalent bovine-human reassortant rotavirus vaccine (BRV-TV)
Number of subjects: 20
Study 24704505 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 22411179 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard part-list cueing condition
Number of subjects: 0
Study 22411179 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradual part-list cueing condition
Number of subjects: 0
Study 22411179 — intervention group
Group type: COMPARATOR
Intervention: Non-cueing condition
Number of subjects: 0
Study 19281324 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Intervention (EI) group received a 12-week lifestyle intervention
Number of subjects: 1021
Study 19281324 — intervention group
Group type: COMPARATOR
Intervention: Minimum Intervention (MI) group
Number of subjects: 1021
Study 17188743 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance use immediately preceding mania
Number of subjects: 170
Study 17188743 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance use preceding mania
Number of subjects: 170
Study 17188743 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance use following mania
Number of subjects: 170
Study 17188743 — intervention group
Group type: EXPERIMENTAL
Intervention: Indeterminable substance use
Number of subjects: 170
Study 15820074 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (intraoperative hypotonic peritoneal chemo-hyperthermia and early postoperative intraperitoneal chemotherapy)
Number of subjects: 156
Study 15820074 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment groups 1 and 2 (combined therapy and intraoperative chemotherapy)
Number of subjects: 156
Study 12549803 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ibuprofen (10 mg/kg/dose for three doses given at 24 hourly intervals)
Number of subjects: 18
Study 12549803 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin (0.2 mg/kg/dose for three doses given at 12 hourly intervals)
Number of subjects: 18
Study 12549803 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ibuprofen
Number of subjects: 18
Study 12549803 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin
Number of subjects: 18
Study 12549803 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ibuprofen and Indomethacin
Number of subjects: 18
Study 9798586 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole 1200 mg
Number of subjects: 622
Study 9798586 — intervention group
Group type: COMPARATOR
Intervention: Pyrantel
Number of subjects: 622
Study 7858933 — intervention group
Group type: COMPARATOR
Intervention: MTC 20 mg i.v. at time zero, MTC 20 mg i.m. after 4 h and 8 h (parenteral injections)
Number of subjects: 12
Study 7858933 — intervention group
Group type: COMPARATOR
Intervention: MTC 40 mg by nasal spray 2 h before chemotherapy, followed by the same dose at 4 h and 8 h (nasal spray)
Number of subjects: 12
Study 2488281 — intervention group
Group type: COMPARATOR
Intervention: Zidovudine (AZT); specific dosage and duration not mentioned
Number of subjects: 0
Study 31073189 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) elements
Number of subjects: 176
Study 28552257 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized liposomal amphotericin B (LAmB) maintenance therapy
Number of subjects: 0
Study 28552257 — intervention group
Group type: COMPARATOR
Intervention: Conventional strategy without antifungal maintenance therapy
Number of subjects: 0
Study 25918337 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient safety culture questionnaire
Number of subjects: 30
Study 25918337 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient safety culture questionnaire + practice-based workshop
Number of subjects: 30
Study 25918337 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 30
Study 23691884 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistive heating (RH)
Number of subjects: 70
Study 23691884 — intervention group
Group type: COMPARATOR
Intervention: Convective warming (CW)
Number of subjects: 70
Study 21348793 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilostazol (200 mg/day) for 8 weeks
Number of subjects: 104
Study 19731700 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestraw Personal water treatment device
Number of subjects: 313
Study 19731700 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 313
Study 17210398 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (1200 mg)
Number of subjects: 245
Study 17210398 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-layer bandages
Number of subjects: 245
Study 17210398 — intervention group
Group type: EXPERIMENTAL
Intervention: Knitted viscose dressings
Number of subjects: 245
Study 15542181 — intervention group
Group type: EXPERIMENTAL
Intervention: CpG 7909
Number of subjects: 0
Study 15542181 — intervention group
Group type: COMPARATOR
Intervention: Alum-adsorbed HBsAg
Number of subjects: 0
Study 15019322 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 0.05% cyclosporin A eyedrops
Number of subjects: 22
Study 15019322 — intervention group
Group type: COMPARATOR
Intervention: Placebo (artificial tears)
Number of subjects: 22
Study 11262208 — intervention group
Group type: EXPERIMENTAL
Intervention: pyrimethamine‐sulfadoxine and 3 doses of artesunate
Number of subjects: 0
Study 11262208 — intervention group
Group type: COMPARATOR
Intervention: pyrimethamine‐sulfadoxine alone
Number of subjects: 0
Study 11262208 — intervention group
Group type: EXPERIMENTAL
Intervention: artesunate (1 or 3 doses)
Number of subjects: 0
Study 11262208 — intervention group
Group type: COMPARATOR
Intervention: pyrimethamine‐sulfadoxine
Number of subjects: 0
Study 9272590 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoglycaemia (at around 3 mmol l(‐1))
Number of subjects: 15
Study 9272590 — intervention group
Group type: COMPARATOR
Intervention: Euglycaemia
Number of subjects: 15
Study 8327279 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine surfactant treatment
Number of subjects: 47
Study 8327279 — intervention group
Group type: COMPARATOR
Intervention: Control (no surfactant treatment)
Number of subjects: 47
Study 3563430 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfadiazine-trimethoprim combination (500 mg + 150 mg) b.i.d. for 3 days
Number of subjects: 132
Study 3563430 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfadiazine-trimethoprim combination (500 mg + 150 mg) b.i.d. for 10 days
Number of subjects: 132
Study 3563430 — intervention group
Group type: EXPERIMENTAL
Intervention: Pivmecillinam (500 mg) t.i.d. for 3 days
Number of subjects: 132
Study 3563430 — intervention group
Group type: EXPERIMENTAL
Intervention: Pivmecillinam (500 mg) t.i.d. for 10 days
Number of subjects: 132
Study 3563430 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfadiazine-trimethoprim combination (10-day regimen)
Number of subjects: 132
Study 3563430 — intervention group
Group type: EXPERIMENTAL
Intervention: Pivmecillinam
Number of subjects: 132
Study 3563430 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfadiazine-trimethoprim (3-day regimen)
Number of subjects: 132
Study 3563430 — intervention group
Group type: COMPARATOR
Intervention: Sulfadiazine-trimethoprim (3-day regimen) and Pivmecillinam (3-day regimen)
Number of subjects: 132
Study 3563430 — intervention group
Group type: COMPARATOR
Intervention: Sulfadiazine-trimethoprim (10-day regimen) and Pivmecillinam (10-day regimen)
Number of subjects: 132
Study 28967984 — intervention group
Group type: EXPERIMENTAL
Intervention: SYM‐1219 2 g
Number of subjects: 52
Study 28967984 — intervention group
Group type: EXPERIMENTAL
Intervention: SYM‐1219 6 g
Number of subjects: 52
Study 28967984 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 28967984 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin (positive control)
Number of subjects: 52
Study 27440710 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronate (5 mg intravenously once per year)
Number of subjects: 105
Study 27440710 — intervention group
Group type: COMPARATOR
Intervention: Alendronate (70 mg orally once per week)
Number of subjects: 105
Study 24458543 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy for Insomnia (CBT-I)
Number of subjects: 113
Study 24458543 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 113
Study 23990917 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant tamoxifen
Number of subjects: 564
Study 23990917 — intervention group
Group type: COMPARATOR
Intervention: No adjuvant treatment
Number of subjects: 564
Study 23990917 — intervention group
Group type: EXPERIMENTAL
Intervention: Wnt‐5a expression
Number of subjects: 564
Study 23990917 — intervention group
Group type: EXPERIMENTAL
Intervention: Wnt‐5a expression in Luminal A tumors
Number of subjects: 564
Study 20524443 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicomild‐2 Sugar Free Gum (2 mg pieces, 6.74%)
Number of subjects: 24
Study 20524443 — intervention group
Group type: COMPARATOR
Intervention: Nicorette Sugar Free (2 mg pieces)
Number of subjects: 24
Study 18514508 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane 25mg daily and celecoxib 400mg twice daily (group A)
Number of subjects: 82
Study 18514508 — intervention group
Group type: COMPARATOR
Intervention: Exemestane 25mg daily (group B)
Number of subjects: 82
Study 18514508 — intervention group
Group type: COMPARATOR
Intervention: Letrozole 2.5mg daily (group C)
Number of subjects: 82
Study 16616168 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio Computer‐Assisted Self‐Interview (ACASI)
Number of subjects: 735
Study 16616168 — intervention group
Group type: COMPARATOR
Intervention: Interviewer‐Administered Questionnaire (IAQ)
Number of subjects: 735
Study 12631367 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 1513
Study 10388245 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with unmet needs
Number of subjects: 94
Study 8891805 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium infusion
Number of subjects: 61
Study 8891805 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 61
Study 1495197 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefdinir 3 mg/kg administered 1 hour before meal (fasting state)
Number of subjects: 17
Study 1495197 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefdinir 3 mg/kg administered 30 minutes after meal
Number of subjects: 17
Study 1495197 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefdinir mean dose of 4.8 mg/kg t.i.d. for 8 days
Number of subjects: 17
Study 6488805 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable (no specific intervention mentioned)
Number of subjects: 0
Study 6488805 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (no specific control mentioned)
Number of subjects: 0
Study 31917467 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous event recording (R-test 4; Novacor)
Number of subjects: 269
Study 31917467 — intervention group
Group type: COMPARATOR
Intervention: Intermittent ECG (Zenicor II)
Number of subjects: 269
Study 31917467 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous event recording
Number of subjects: 269
Study 31917467 — intervention group
Group type: COMPARATOR
Intervention: Intermittent ECG
Number of subjects: 269
Study 30660059 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention (4 sessions)
Number of subjects: 44
Study 30660059 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 44
Study 28045051 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined physical-cognitive training for 7 months
Number of subjects: 113
Study 28045051 — intervention group
Group type: COMPARATOR
Intervention: Usual life (control group)
Number of subjects: 113
Study 26003882 — intervention group
Group type: EXPERIMENTAL
Intervention: Supreme Laryngeal Mask Airway (SLMA)
Number of subjects: 142
Study 26003882 — intervention group
Group type: COMPARATOR
Intervention: Face Mask
Number of subjects: 142
Study 23588865 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/ml (total 2 ml) esmolol
Number of subjects: 90
Study 23588865 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg lidocaine
Number of subjects: 90
Study 23588865 — intervention group
Group type: COMPARATOR
Intervention: 2 ml saline
Number of subjects: 90
Study 21271613 — intervention group
Group type: EXPERIMENTAL
Intervention: Zibotentan 15 mg plus docetaxel 75 mg/m²
Number of subjects: 26
Study 21271613 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus docetaxel 75 mg/m²
Number of subjects: 26
Study 19558010 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol use
Number of subjects: 114